Tacrolimus Capsules

DRUG6 trials

Conditions

HealthyHeart TransplantationKidney TransplantKidney TransplantationLiver TransplantationLupus NephritisPrimary Focal Segmental Glomerulosclerosis (FSGS)

Phase 1

Bioavailability Study of Tacrolimus Capsules, 5 mg of Dr. Reddy's Under Fasting Conditions

CompletedNCT01131988

Dr. Reddy's Laboratories LimitedHealthy

Start: 2008-01-31End: 2008-03-31Updated: 2010-06-14

Bioavailability Study of Tacrolimus Capsules, 5 mg of Dr. Reddys's Laboratories Limited Under Non-Fasting Conditions

CompletedNCT01132027

Dr. Reddy's Laboratories LimitedHealthy

Start: 2008-01-31End: 2008-03-31Updated: 2010-06-14

Phase 2

Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients

CompletedNCT02921789

Astellas Pharma Global Development, Inc.Kidney Transplantation, Primary Focal Segmental Glomerulosclerosis (FSGS)

Start: 2017-05-22End: 2021-05-18Updated: 2024-12-04

Phase 3

A Study to Compare the Efficacy and Safety of Tacrolimus Capsules and Cyclophosphamide Injection in Treatment of Lupus Nephritis

CompletedNCT02457221

Astellas Pharma China, Inc.Lupus Nephritis

Start: 2015-03-10End: 2018-09-10Updated: 2024-11-01

Phase 4

A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft Recipients

TerminatedNCT01371344

Astellas Pharma Europe Ltd.Heart Transplantation, Kidney Transplantation, Liver Transplantation

Start: 2011-06-24End: 2017-04-02Updated: 2024-11-01

Study to Evaluate the Pharmacokinetics and Tolerability of Tacrolimus in Kidney Transplant Recipients.

NCT04102943

Chong Kun Dang PharmaceuticalKidney Transplant

Start: 2017-11-30End: 2021-01-10Target: 128Updated: 2020-01-09

Related Papers

Effect of Tacrolimus vs Intravenous Cyclophosphamide on Complete or Partial Response in Patients With Lupus Nephritis

JAMA Network Open2022-03-3058 citations